Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs Valsartan Efficacy After Missed Dose in Hypertension
NCT00819767Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Feb 2009; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00819767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819767.